XRAY vs. WST
Compare and contrast key facts about DENTSPLY SIRONA Inc. (XRAY) and West Pharmaceutical Services, Inc. (WST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XRAY or WST.
Correlation
The correlation between XRAY and WST is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
XRAY vs. WST - Performance Comparison
Loading data...
Key characteristics
XRAY:
-0.84
WST:
-0.71
XRAY:
-0.98
WST:
-0.67
XRAY:
0.84
WST:
0.87
XRAY:
-0.48
WST:
-0.65
XRAY:
-1.33
WST:
-1.75
XRAY:
29.03%
WST:
22.17%
XRAY:
47.07%
WST:
54.91%
XRAY:
-80.50%
WST:
-59.29%
XRAY:
-74.06%
WST:
-53.63%
Fundamentals
XRAY:
$3.29B
WST:
$15.14B
XRAY:
-$4.47
WST:
$6.37
XRAY:
0.93
WST:
3.54
XRAY:
0.88
WST:
5.23
XRAY:
1.64
WST:
5.64
XRAY:
$3.72B
WST:
$2.90B
XRAY:
$1.92B
WST:
$1.00B
XRAY:
-$576.00M
WST:
$729.50M
Returns By Period
In the year-to-date period, XRAY achieves a -11.10% return, which is significantly higher than WST's -33.76% return. Over the past 10 years, XRAY has underperformed WST with an annualized return of -9.86%, while WST has yielded a comparatively higher 15.27% annualized return.
XRAY
-11.10%
32.02%
-6.92%
-39.30%
-13.70%
-9.86%
WST
-33.76%
3.69%
-31.00%
-38.64%
0.47%
15.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
XRAY vs. WST — Risk-Adjusted Performance Rank
XRAY
WST
XRAY vs. WST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for DENTSPLY SIRONA Inc. (XRAY) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
XRAY vs. WST - Dividend Comparison
XRAY's dividend yield for the trailing twelve months is around 3.83%, more than WST's 0.38% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XRAY DENTSPLY SIRONA Inc. | 3.83% | 3.37% | 1.57% | 1.57% | 0.77% | 0.76% | 0.66% | 0.95% | 0.53% | 0.54% | 0.48% | 0.50% |
WST West Pharmaceutical Services, Inc. | 0.38% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
Drawdowns
XRAY vs. WST - Drawdown Comparison
The maximum XRAY drawdown since its inception was -80.50%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for XRAY and WST. For additional features, visit the drawdowns tool.
Loading data...
Volatility
XRAY vs. WST - Volatility Comparison
DENTSPLY SIRONA Inc. (XRAY) has a higher volatility of 16.82% compared to West Pharmaceutical Services, Inc. (WST) at 11.24%. This indicates that XRAY's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
XRAY vs. WST - Financials Comparison
This section allows you to compare key financial metrics between DENTSPLY SIRONA Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XRAY vs. WST - Profitability Comparison
XRAY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DENTSPLY SIRONA Inc. reported a gross profit of 466.00M and revenue of 879.00M. Therefore, the gross margin over that period was 53.0%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a gross profit of 231.90M and revenue of 698.00M. Therefore, the gross margin over that period was 33.2%.
XRAY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DENTSPLY SIRONA Inc. reported an operating income of 63.00M and revenue of 879.00M, resulting in an operating margin of 7.2%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported an operating income of 107.00M and revenue of 698.00M, resulting in an operating margin of 15.3%.
XRAY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DENTSPLY SIRONA Inc. reported a net income of 20.00M and revenue of 879.00M, resulting in a net margin of 2.3%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a net income of 89.80M and revenue of 698.00M, resulting in a net margin of 12.9%.